Rates of undetectable HBV at one year of
therapy in randomized clinical trials in patients with CHB monoinfection
%
EASL HBV Guidelines. J.
Hepatology 2009;50:227−242. Chung YH et al AASLD 2006 Abstract LB19
These trials used different HBV
DNA assays and were not head- to- head comparisons for all the drugs; thus, these numbers
are only indicative and should be considered with caution